(VIANEWS) – The NASDAQ ended the session with Sorrento Therapeutics rising 6.97% to $2.15 on Friday, after two sequential sessions in a row of gains. NASDAQ jumped 0.9% to $11,127.84, after four sequential sessions in a row of losses, on what was a somewhat positive trend trading session today.


Today’s last reported volume for Sorrento Therapeutics is 8125640, 20.82% below its average volume of 10262300.

Sorrento Therapeutics’s last close was $2.01, 81.84% under its 52-week high of $11.07.

Sorrento Therapeutics’s Sales

Sorrento Therapeutics’s sales growth is 29% for the current quarter and 85.1% for the next. The company’s growth estimates for the ongoing quarter is a negative 1700% and positive 77.2% for the next.

Sorrento Therapeutics’s Revenue

Year-on-year quarterly revenue growth grew by 13.7%, now sitting on 52.9M for the twelve trailing months.

Sorrento Therapeutics’s Stock Yearly Top and Bottom Value

Sorrento Therapeutics’s stock is valued at $2.15 at 19:14 EST, way under its 52-week high of $11.07 and way above its 52-week low of $1.15.

Sorrento Therapeutics’s Moving Average

Sorrento Therapeutics’s value is way higher than its 50-day moving average of $1.65 and way under its 200-day moving average of $4.08.

More news about Sorrento Therapeutics (SRNE).


Please enter your comment!
Please enter your name here